Skip to content

Iradimed upgraded to buy by Roth

July 31, 2017

Roth Capital analyst Chris Lewis upgraded Iradimed Corp (NASDAQ: IRMD) to Buy today. The company’s shares closed on Friday at $9.80, close to its 52-week high of $19.73.

http://bit.ly/2uQn7Ch

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: